c-myc mRNA has been established as a potential biomarker for detecting cancer, thanks to its critical function as a tumor suppressor or oncogene. Abnormal mRNA expression, in particular, is often seen during the development of early stage colon cancer. As a result, sensitive and specific detection of c-myc mRNA offers a potential way to make an early diagnosis of cancer, and has potential for the development of precision medicine.
Micro and nanorobots that attack tumors with the most precision using drug could be the way to combat cancer in the future. The development of magnetoelectric-controlled Janus machines by a team of ETH researchers, headed by Salvador Pané, has the potential for such advances.
Researchers at the Houston Methodist Research Institute have developed a unique drug that effectively removes lung metastases in mice. This latest breakthrough may radically redefine the treatment of metastatic triple negative breast cancer.
Atherosclerosis is a disease that causes a buildup of plaque in arteries. The disease is an invisible and prolific killer, but its ability to hide in the body and create havoc may soon be lost. A new nanoparticle has been developed by scientists, that acts as if it were a high-density lipoprotein (HDL). The nanoparticle can light up as well as treat the plaques that clog the arteries. This therapy technique can potentially assist to prevent strokes and heart attacks.
Liposomes are an existing drug delivery vehicle, but they are detected by the immune system. Researchers from the universities of Basel and Fribourg have demonstrated that specially synthesized liposomes do not produce any reaction in human and porcine sera, as well as pigs.
With support from the state of Florida, Mayo Clinic’s Florida campus has opened a state-of-the-art laboratory for nanotechnology research, an emerging field of science that studies and applies materials that are the size of an atom.
Researchers at Karolinska Institutet have developed a nanoparticle technology that can be used to stabilise membrane proteins so that their structure can be studied in a lipid environment. The method, described in Nature Methods, makes it possible to access drug targets that previously could not be investigated and therefore potentially allows for the development of novel drugs, therapeutic antibodies and vaccines.
A scientific innovator, whose achievements range from developing diagnostic biochips to creating nanoscale cancer-fighting “smart bullets” that deliver treatments to tumor cells, has been recruited to the OHSU Knight Cancer Institute to lead the first large-scale early cancer detection program of its kind.
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. It is a leading cause of death and the burden is expected to grow worldwide due to the growth and aging of the population, mainly in less developed countries, in which about 82% of the world's population resides.
Recent research on graphene oxide may enhance our ability to fight infections acquired from hospitals and other places. Researchers from the Università Cattolica del Sacro Cuore in Rome are analyzing graphene oxide in the hope of successfully developing bacteria-killing medical devices and catheters in the near future. Bacteria can be killed by coating all surgical equipment with the carbon-based compounsd. This will result in faster recovery times, reducing the number of post-operative infections, and reducing the requirement for antibiotics.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.